COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Maria Belen Delany, Mark Bower et al.|Therapeutic Advances in Medical Oncology|2021Cited by 7
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trialGerardo Rosati, Roberto Labianca, Chiara Alessandra Cella et al.|Gastric Cancer|2022Cited by 4